Pfizer Inc.
PFE
$25.60
-$0.10-0.39%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.58B | 4.86B | 6.92B | 7.84B | 7.88B |
| Total Depreciation and Amortization | 4.93B | 4.93B | 5.06B | 5.15B | 6.88B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.24B | 2.86B | 709.00M | 893.00M | 879.00M |
| Change in Net Operating Assets | -178.00M | -365.00M | 971.00M | 1.89B | -1.65B |
| Cash from Operations | 12.57B | 12.29B | 13.66B | 15.77B | 13.99B |
| Capital Expenditure | -1.88B | -2.01B | -2.08B | -2.13B | -2.77B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -6.93B | -6.93B | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.02B | 3.64B | 1.30B | 1.73B | 6.96B |
| Cash from Investing | -7.79B | -5.30B | -779.00M | -406.00M | 4.19B |
| Total Debt Issued | 5.99B | 5.99B | 732.00M | 2.89B | 7.46B |
| Total Debt Repaid | -3.03B | -5.33B | -5.88B | -10.30B | -14.88B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.33B | -7.33B | -7.26B | -7.20B | -9.58B |
| Other Financing Activities | -367.00M | -439.00M | -409.00M | -376.00M | -439.00M |
| Cash from Financing | -4.74B | -7.11B | -12.82B | -14.98B | -17.44B |
| Foreign Exchange rate Adjustments | 26.00M | 0.00 | -34.00M | -27.00M | -45.00M |
| Miscellaneous Cash Flow Adjustments | 2.00M | 1.00M | 1.00M | -2.00M | -1.00M |
| Net Change in Cash | 66.00M | -123.00M | 29.00M | 358.00M | 701.00M |